OLER ABRAHAM N. 4
4 · Onconova Therapeutics, Inc. · Filed Jan 31, 2022
Insider Transaction Report
Form 4
OLER ABRAHAM N.
VP Corp Dev & Gen Counsel
Transactions
- Purchase
Common Stock
2022-01-28$1.67/sh+1,500$2,505→ 24,514 total
Footnotes (2)
- [F1]The purchases reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
- [F2]Includes 10,333 shares held by the Abraham Oler Living Trust U/T/A DTD 07/27/2012, of which the reporting person is a trustee.